Searchable abstracts of presentations at key conferences in endocrinology

ea0035p1088 | Thyroid Cancer | ECE2014

Estimated 10-year risk of bone fracture in women with diffentiated thyroid cancer on TSH-suppressive levo-thyroxine therapy

Vera Lara , Gay Stefano , Campomenosi Claudia , Mortara Lorenzo , Pera Giorgia , Monti Eleonora , Minuto Francesco , Giusti Massimo

After thyroidectomy (Tx) and RAI therapy, patients with diffentiated thyroid cancer are treated with levo-thyroxine to suppress TSH levels. Whether hyperthyroxinemia causes osteoporosis is debated. The aim of this study was to evaluate bone mineral density (BMD) and the fracture risk assessment tool (FRAX) in DTC women. FRAX calculates the 10-year probability of hip fracture (HF) and major osteoporotic fracture (MOF) in subjects aged >40. 46 women with DTC diagnosed and tr...

ea0020p252 | Bone/Calcium | ECE2009

Metabolic and cardiovascular risk in primary hyperparathyroidism

Dolcino Mara , Massaro Francesca , Vera Lara , Oddo Silvia , Rodriguez Guido , Ferone Diego , Minuto Francesco , Giusti Massimo

Background: Primary hyperparathyroidism (PHP) is associated with increased rates of cardiovascular (CV) risk. Moreover, it is not fully clear whether surgery can attenuate CV risk. The intima-media thickness (IMT) of carotid vessels is considered a marker of atherosclerosis and CV events.Aim: Of the study was to evaluate IMT and some metabolic parameters in PHP patients.Subjects: Of 56 subjects were studied. Patients were divided i...

ea0016p458 | Neuroendocrinology | ECE2008

Effect of GH replacement on coronary flow reserve (CFR) and on some cardiovascular risk factors in adult GHD patients

Boschetti Mara , Agosti Sergio , Albanese Valeria , Casalino Laura , Vera Lara , Goglia Umberto , Paolo Bezante Gian , Ferone Diego , Minuto Francesco

GH deficiency (GHD) negatively influences cardiovascular function directly by impairing cardiac filling, performance, and contractility and indirectly by inducing atherosclerotic changes, hypercoagulability, abdominal obesity, insulin resistance, dislipidemia, endothelial dysfunction, etc. This accounts for the reduced life expectancy and increased risk of death for vascular disease in these patients.CFR represents the capacity of the coronary circulatio...